Recognizing the limitations of handheld ECHO for patients with COVID-19

7th Jan 2021

Although handheld echocardiography (HHE) has a unique role in the current clinical era, it is not without limitations. 

 

Handheld echocardiography has limited modalities

The majority of HHE devices are limited to two-dimensional (2D) and color Doppler modalities. Therefore, they do not have the full functionality of a standard echocardiography machine, such as M-mode and spectral Doppler modalities. 

Multi-component illustration of a handheld echocardiography (HHE) device displaying a 2D color modality beside a standard echocardiography machine displaying M-mode and spectral doppler functions.

Figure 1. Handheld echocardiography (HHE) devices are limited to 2D and color Doppler modalities. They do not have M-mode and spectral Doppler functions, which are found in standard echocardiography machines.  

 

Interpretation challenges 

Due to these limited functionalities, the common interpretation challenges of echocardiography may be more difficult to overcome. In COVID-positive patients with changing hemodynamics, lung consolidation, rhythm disturbances, patient positioning, and artifacts from indwelling lines all pose challenges to interpretation of images. 

Illustration of ventilated patient with COVID-19 in an intensive care unit.

Figure 2. In COVID-positive patients with changing hemodynamics, lung consolidation, rhythm disturbances, patient positioning, and artifacts from indwelling lines all pose challenges to the interpretation of images from a handheld echocardiography machine.

 

Clickable call to action, "Start learning for free", with direct link to sign up for a free Medmastery trial account.

 

Valvular disease assessment

The restricted functionalities of HHE also pose a particular challenge in the assessment of valvular heart disease. Handheld echocardiography can clarify auscultatory findings but determining the severity of valve lesions is complex and requires high-resolution imaging with spectral Doppler for hemodynamic assessment. Therefore, valvular lesions suspected to be beyond mild in severity should be referred for standard transthoracic echocardiography at a suitable time.

Multi-component illustration of caution sign and heart with valves highlighted.

Figure 3. The restricted functionalities of handheld echocardiography (HHE) devices pose a challenge for the assessment of valvular heart disease. Valvular lesions suspected to be beyond mild in severity should be referred for standard transthoracic echocardiography. 

 

Heart rhythm assessment

Another limitation is that HHE devices do not usually come with electrocardiogram (ECG) capability. Although in the intensive care unit (ICU) setting the heart rhythm can be appreciated from the heart monitor, in other situations it can become a challenge if the rhythm was not noted during the scan. 

Illustration of crossed-out heartbeat.

Figure 4. Handheld echocardiography (HHE) devices do not have electrocardiogram (ECG) capacity. 

 

Operator proficiency

Since the aim when performing HHE in the COVID-19 era is to limit scanning time, it is necessary that these focused studies are performed by suitably qualified individuals. The operator should understand the fundamentals of cardiac ultrasound image acquisition and optimization and have the necessary in-depth knowledge of cardiac anatomy and physiology, in order to quickly obtain high-quality images at the bedside. 

Illustration of a male operator with a medal on lapel holding a handheld echocardiography (HHE) device.

Figure 5. The handheld echocardiography (HHE) device operator should understand the fundamentals of cardiac ultrasound image acquisition and optimization, and have the necessary in-depth knowledge of cardiac anatomy and physiology in order to obtain high-quality images. 

Regardless of the limitations, to ensure high clinical standards, education and training are key considerations for HHE. Therefore, a guided protocol is essential to ensure clinical governance in the evolving role of handheld echocardiography. 

 

That’s it for now. If you want to improve your understanding of key concepts in medicine, and improve your clinical skills, make sure to register for a free trial account, which will give you access to free videos and downloads. We’ll help you make the right decisions for yourself and your patients.

Recommended reading

  • Chamsi-Pasha, MA, Sengupta, PP, and Zoghbi, WA. 2017. Handheld echocardiography: Current state and future perspectives. Circulation136: 2178–2188. PMID: 29180495
  • Clerkin, KJ, Fried, JA, Raikhelkar, J, et al. 2020. COVID-19 and cardiovascular disease. Circulation141: 1648–1655. PMID: 32200663
  • Doyen, D, Moceri, P, Ducreux, D, et al. 2020. Myocarditis in a patient with COVID-19: A cause of raised troponin and ECG changes. Lancet395: 1516. PMID: 32334650
  • Drake, DH, De Bonis, M, Covella, M, et al. 2020. Echocardiography in pandemic: Front-line perspective, expanding role of ultrasound and ethics of resource allocation. J Am Soc Echocardiogr33: 683–689. PMID: 32503707
  • Fukuhara, S, Rosati, CM, and El-Dalati, S. 2020. Acute type A aortic dissection during the COVID-19 outbreak. Ann Thorac Surg. 110: e405–e407. PMID: 32333849
  • Haji, K, Wong, C, Neil, C, et al. 2019. Handheld ultrasound to reduce requests for inappropriate echocardiogram (HURRIE). Echo Res Pract6: 91–96. PMID: 31516721
  • Hua, A, O’Gallagher, K, Sado, D, et al. 2020. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J41: 2130. PMID: 32227076
  • Johri, AM, Galen, B, Kirkpatrick, JN, et al. 2020. ASE statement on point-of-care ultrasound during the 2019 novel coronavirus pandemic. J Am Soc Echocardiogr33: 670–673. PMID: 32503704
  • Meyer, P, Degrauwe, S, Van Delden, C, et al. 2020. Typical takotsubo syndrome triggered by SARS-CoV-2 infection. Eur Heart J41: 1860. PMID: 32285915
  • Neskovic, AN, Hagendorff, A, Lancellotti, P, et al. 2013. Emergency echocardiography: The European association of cardiovascular imaging recommendations. Eur Heart J Cardiovasc Imaging14: 1–11. PMID: 23239795
  • Nguyen, VTQ, Ho, JE, Ho, CY, et al. 2008. Handheld echocardiography offers rapid assessment of clinical volume status. Am Heart J156: 537–542. PMID: 18760138
  • Poissy, J, Goutay, J, Caplan, M, et al. 2020. Pulmonary embolism in patients with COVID-19: Awareness of an increased prevalence. Circulation142: 184–186. PMID: 32330083
  • Shi, S, Qin, M, Shen, B, et al. 2020. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol5: 802–810. PMID: 32211816
  • The American Society of Echocardiography. ASE statement on protection of patients and echocardiography service providers during the 2019 novel coronavirus outbreak. 2020. ASEcho.org. https://www.asecho.org  
  • The American Society of Echocardiography. Cleaning recommendations from ultrasound manufacturers. 2020. ASEcho.org. https://www.asecho.org
  • The Department of Health and Social Care (DHSC), Public Health Wales (PHW), Public Health Agency (PHA) Northern Ireland, Health Protection Scotland (HPS) and Public Health England. COVID-19: Guidance for infection prevention and control in healthcare settings. Version 1.0. 2020. rcslt.org. https://www.rcslt.org 
  • Zeng, JH, Liu, YX, Yuan, J, et al. 2020. First case of COVID-19 complicated with fulminant myocarditis: A case report and insights. Infection48: 773–777. PMID: 32277408